Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 14c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.85), $0.14 better than the analyst estimate of ($0.99).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c